Davide Campagnol

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The advent of nanocarriers for drug delivery has given rise to new intriguing scenarios in the cancer field. Nanocarriers indeed partly overcome the limits of traditional cytotoxic drugs principally changing the pharmacokinetic behavior of the parental drug. The peculiar characteristics of these systems strongly minimize the adverse reactions and ensure a(More)
  • 1